Full versus abbreviated lead-in durations of apixaban and rivaroxaban after initial parenteral anticoagulation in the treatment of venous thromboembolism
Full versus abbreviated lead-in durations of apixaban and rivaroxaban after initial parenteral anticoagulation in the treatment of venous thromboembolism. // Thrombosis Research. – URL: https://www.sciencedirect.com/science/article/pii/S0049384826002574?dgcid=rss_sd_all
Full versus abbreviated lead-in durations of apixaban and rivaroxaban after initial parenteral anticoagulation in the treatment of venous thromboembolism. Thrombosis Research. https://www.sciencedirect.com/science/article/pii/S0049384826002574?dgcid=rss_sd_all
“Full versus abbreviated lead-in durations of apixaban and rivaroxaban after initial parenteral anticoagulation in the treatment of venous thromboembolism.” Thrombosis Research.
@article{article69597,
title = {Full versus abbreviated lead-in durations of apixaban and rivaroxaban after initial parenteral anticoagulation in the treatment of venous thromboembolism},
journal = {Thrombosis Research},
url = {https://www.sciencedirect.com/science/article/pii/S0049384826002574?dgcid=rss_sd_all}
}